Abstract
Malignant ovarian germ cell tumours represent up to 5% of malignant ovarian masses and predominantly affects young women most commonly less than 30 years old. MOGCT originate from the primordial germ cells of the ovary; the tumor types are divided into dysgerminoma and non dysgerminoma types. The overall prognosis when diagnosed early is excellent and due to early stage presentation and chemosensitive nature of the tumours. MOGCTs are rapidly progressive tumours with a propensity to metastasize quickly, therefore expeditious diagnosis and treatment is the cornerstone of their management.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Low JJ, Ilancheran A, Ng JS. Malignant ovarian germ-cell tumours. Best Pract Res Clin Obstet Gynaecol. 2012;26(3):347–55.
Uccello M, Boussios S, Samartzis EP, Moschetta M. Systemic anti-cancer treatment in malignant ovarian germ cell tumours (MOGCTs): current management and promising approaches. Ann Transl Med. 2020;8(24):1713.
Tîrnovanu MC, Florea ID, Tănase A, et al. Uncommon metastasis of ovarian dysgerminoma: a case report and review of the literature. Medicina (Kaunas). 2021;57(6):534.
Cheung A, Shah S, Parker J, Soor P, Limbu A, Sheriff M, Boussios S. Non-epithelial ovarian cancers: how much do we really know? Int J Environ Res Public Health. 2022;19(3):1106.
Ray-Coquard I, Morice P, Lorusso D, Prat J, Oaknin A, Pautier P, Colombo N, ESMO Guidelines Committee. Non-epithelial ovarian cancer: ESMO clinical practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv1–iv18.
Ajao M, Vachon T, Snyder P. Ovarian dysgerminoma: a case report and literature review. Mil Med. 2013;178(8):e954–5.
Zhang XW, Zhai LR, Huang DW, Jiang ZD, Yu T, Liu SY, Cui MH. Pregnancy with giant ovarian dysgerminoma: a case report and literature review. Medicine (Baltimore). 2020;99(41):e21214.
Devaja O, Papadopoulos A. Current management of immature teratoma of the ovary. Arch Oncol. 2000;8(3):127–9.
de La Motte Rouge T, Pautier P, Rey A, Duvillard P, Kerbrat P, Troalen F, Morice P, Haie-Meder C, Culine S, Lhommé C. Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases. Eur J Cancer. 2011;47(2):175–82.
Satoh T, Aoki Y, Kasamatsu T, et al. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour. Eur J Cancer. 2015;51(3):340–51.
Wang D, Cang W, Zhu S, Jia C, Cao D, Yang J, Xiang Y. Oncological and reproductive outcomes in patients with advanced-stage ovarian immature teratoma: experience from a tertiary center. Front Oncol. 2022;12:822341.
Li S, Liu Z, Dong C, Long F, Liu Q, Sun D, Gao Z, Wang L. Growing teratoma syndrome secondary to ovarian giant immature teratoma in an adolescent girl: a case report and literature review. Medicine (Baltimore). 2016;95(7):e2647.
Wang D, Zhu S, Jia C, Cao D, Wu M, Shen K, Yang J, Pan L, Cheng N, Xiang Y. Diagnosis and management of growing teratoma syndrome after ovarian immature teratoma: a single center experience. Gynecol Oncol. 2020;157(1):94–100.
Wang D, Jia CW, Feng RE, Shi HH, Sun J. Gliomatosisperitonei: a series of eight cases and review of the literature. J Ovarian Res. 2016;9(1):45.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Olaoye, T. (2023). Malignant Ovarian Germ Cell Tumours. In: Singh, K., Gupta, B. (eds) Case-Based Gynecological Oncology. Springer, Cham. https://doi.org/10.1007/978-3-031-36179-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-031-36179-1_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-36178-4
Online ISBN: 978-3-031-36179-1
eBook Packages: MedicineMedicine (R0)